Evaluation of the Phosphodiesterase 3 Inhibitor ORG 9935 as a Contraceptive in Female Macaques: Initial Trials

Contraception - United States
doi 10.1016/j.contraception.2009.09.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Evaluation of Remotely Delivered Leuprolide Acetate as a Contraceptive Agent in Female Elk (Cervus Elaphus Nelsoni)

Journal of Wildlife Diseases
EvolutionEcologySystematicsBehavior
2005English

A Dose-Ranging Study of the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in COPD

Respiratory Research
PulmonaryRespiratory Medicine
2020English

The Inotropic Effects of UK 14,275, a Phosphodiesterase Inhibitor, in Man.

British Journal of Clinical Pharmacology
Pharmacology
1978English

Future Prospective of Phosphodiesterase-3 Inhibitors as Antithorombotic Drug

Japanese Journal of Thrombosis and Hemostasis
2011English

Ab Initiostructure Determination of a New Phosphodiesterase Enzyme Inhibitor

Acta Crystallographica Section A Foundations of Crystallography
2011English

Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

Rheumatology and Therapy
2014English

Therapeutic Potential of a New Phosphodiesterase Inhibitor in Acute Lung Injury

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2003English

The Phosphodiesterase 3 Inhibitor Cilostazol Dilates Large Cerebral Arteries in Humans Without Affecting Regional Cerebral Blood Flow

Journal of Cerebral Blood Flow and Metabolism
NeurologyCardiovascular MedicineCardiology
2004English

3. Initial Evaluation and Diabetes Management Planning

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy